IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Titan Pharmaceuticals Inc de

CUSIP: 888314957 | 3 institutional holders

Quarters

Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile